Atlas Trials

A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034

Clinical trial NCT01813812 · UNKNOWN

Trial details

NCT number
NCT01813812
Sponsor
Dong-A Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Acute GastritisChronic Gastritis
Start date
2010-10-01
Primary completion
2013-08-01
Enrollment
492

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.